McKesson Corporation dba McKesson Drug Company 2022-05-11 Health serious FDA
Health · FDA · Recall #FDA-D-0851-2022
Erythromycin Topical Gel USP, 2%, Net Wt 60 g tube, Rx only, Manufactured by: Teligent… Recall
Issued May 11, 2022 · McKesson Corporation dba McKesson Drug Company
In May 2022, McKesson Corporation dba McKesson Drug Company recalled the Erythromycin Topical Gel USP, 2%, Net Wt 60 g tube, Rx only, Manufactured by: Teligent…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.
What you should do
- 1 Stop using Erythromycin Topical Gel USP, 2%, Net Wt 60 g tube, Rx only, Manufactured by: Teligent… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact McKesson Corporation dba McKesson Drug Company to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- McKesson Corporation dba McKesson Drug Company
- Category
- Health
- Recall date
- May 11, 2022
- Units affected
- Not reported
- Sold at
- Nationwide in the United States including Guam and the Northern Mariana Islands.
- Recall number
- FDA-D-0851-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- McKesson Corporation dba McKesson Drug Company has 2 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.